STOCK TITAN

Inmode Ltd. (INMD) Financials

INMD
FY2025 annual
Revenue $370.5M -6.2% YoY
Net Income $93.8M -48.2% YoY
EPS (Diluted) $1.43 -36.4% YoY
Free Cash Flow $84.3M -36.1% YoY
Market Cap $851.1M as of Sep 10, 2026
Price / Sales 2.3x on $370.5M revenue, FY2025
Price / Earnings 9.1x on $93.8M net income, FY2025
Price / Book 1.2x on $683.2M equity, Q4 FY2025

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD FYE December

Newest figures come from the 20-F for FY2025, filed Feb 10, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the INMD SEC filings page.

Inmode Ltd. (INMD) reported $370.5M in revenue for fiscal year 2025, down 6.2% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI INMD FY2025

Contracting profitability and cash generation coexist with a lightly leveraged balance sheet, inventory buildup, and continued share repurchases.

In FY2024, net income of $181M exceeded operating cash flow of $133M, a gap consistent with the reported tax benefit lifting accounting profit without an equal cash inflow. In FY2025, the gap narrowed to $9M even as operating margin fell to 23.1%, so the lower earnings base converted to cash more closely.

Revenue declined from $492M in FY2023 to $370M in FY2025, making fixed costs and mix more consequential. Gross margin narrowed to 78.5% over that span, indicating the slowdown also carried less favorable economics per sales dollar.

FY2025 liabilities of $83M against $766M of assets indicate low balance-sheet dependence on creditors. Against that conservative posture, inventory rose from $45M in FY2023 to $74M in FY2025 as revenue contracted, while buybacks continued; capital was being returned even as more was tied in stock.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 74 / 100
Financial Health Score 74/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Inmode Ltd.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
88

Inmode Ltd. has an operating margin of 23.1%, meaning the company retains $23 of operating profit per $100 of revenue. This strong profitability earns a score of 88/100, reflecting efficient cost management and pricing power. This is down from 28.5% the prior year.

Growth
7

Inmode Ltd.'s revenue declined 6.2% year-over-year, from $394.8M to $370.5M. This contraction results in a growth score of 7/100.

Leverage
79

Inmode Ltd. carries a low D/E ratio of 0.12, meaning only $0.12 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 79/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
98

With a current ratio of 9.88, Inmode Ltd. holds $9.88 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 98/100.

Cash Flow
94

Inmode Ltd. converts 22.8% of revenue into free cash flow ($84.3M). This strong cash generation earns a score of 94/100.

Returns
75

Inmode Ltd. earns a strong 13.7% return on equity (ROE), meaning it generates $14 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 75/100. This is down from 25.8% the prior year.

Altman Z-Score Safe
9.74

Inmode Ltd. scores 9.74, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($851.1M) relative to total liabilities ($83.2M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
3/8

Inmode Ltd. passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Mixed
0.91x

For every $1 of reported earnings, Inmode Ltd. generates $0.91 in operating cash flow ($85.3M OCF vs $93.8M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

None of these metrics is reported for Q4 2025.

Cash & Balance Sheet

Cash & Debt
$302.5M
YoY+94.8%
QoQ+94.8%

Inmode Ltd. held $302.5M in cash as of Q4 2025; long-term debt is not reported for that period.

Shares Outstanding
63M
YoY-8.9%
QoQ-8.9%

Inmode Ltd. had 63M shares outstanding in Q4 2025. This represents a decrease of 8.9% from the same quarter a year earlier. Against the prior quarter it is down 8.9%.

Free Cash Flow

Not reported for Q4 2025.

Dividends Per Share

Not reported for Q4 2025.

Margins & Returns

None of these metrics is reported for Q4 2025.

Capital Allocation

None of these metrics is reported for Q4 2025.

INMD Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

INMD quarterly income statement
MetricQ4'2520-FQ4'2420-FQ4'2310-KQ4'2210-KQ4'2110-KQ4'2010-KQ4'1910-KQ4'1810-K

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

INMD Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

INMD quarterly balance sheet
MetricQ4'2520-FQ4'2420-FQ4'2310-KQ4'2210-KQ4'2110-KQ4'2010-KQ4'1910-KQ4'1810-K
Total Assets$766.4M-2.4%$785.7M-9.0%$863.3M+34.0%$644.4M+34.7%$478.5M+61.8%$295.8M+35.4%$218.4M+169.4%$81.1M
Current Assets$698.6M-2.2%$714.5M-15.5%$845.3M+34.3%$629.4M+33.9%$470.1M+62.3%$289.6M+35.8%$213.2M+174.2%$77.8M
Cash & Equivalents$302.5M+94.8%$155.3M+7.6%$144.4M+48.1%$97.5M+43.2%$68.1M-1.2%$68.9M+54.1%$44.7M+80.9%$24.7M
Short-Term Investments$83.6M-68.8%$267.7M-28.4%$373.6M-0.3%$374.6M+27.2%$294.5M+107.4%$142.0M+18.2%$120.1M+352.8%$26.5M
Inventory$74.0M+24.4%$59.5M+32.1%$45.1M+13.0%$39.9M+89.8%$21.0M+40.3%$15.0M+59.3%$9.4M+35.1%$7.0M
Accounts Receivable$43.5M+19.7%$36.3M-14.2%$42.4M+56.9%$27.0M+33.4%$20.2M+92.7%$10.5M+58.4%$6.6M-5.4%$7.0M
Long-Term Investments$0$0$0$0$0$0$0$0
Total Liabilities$83.2M+1.7%$81.9M+7.8%$75.9M-15.5%$89.8M+43.1%$62.7M+55.7%$40.3M+4.4%$38.6M+12.8%$34.2M
Current Liabilities$70.7M+1.3%$69.9M+8.9%$64.1M-21.8%$82.0M+58.2%$51.9M+48.0%$35.0M+7.8%$32.5M+10.4%$29.4M
Non-Current Liabilities$12.5M+4.0%$12.0M+1.9%$11.8M+51.6%$7.8M-28.6%$10.9M+107.2%$5.3M-13.7%$6.1M+27.8%$4.8M
Total Equity$683.2M-2.9%$703.8M-10.6%$787.4M+42.0%$554.6M+33.4%$415.8M+63.7%$254.0M+44.2%$176.1M+307.0%$43.3M
Retained Earnings$968.5M+10.7%$874.7M+26.1%$693.4M+39.9%$495.5M+48.4%$334.0M+97.6%$169.0M+79.8%$94.0M+185.1%$33.0M

Not reported in any period shown, so not listed: Goodwill, Long-Term Debt.

INMD Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

INMD quarterly cash flow statement
MetricQ4'2520-FQ4'2420-FQ4'2310-KQ4'2210-KQ4'2110-KQ4'2010-KQ4'1910-KQ4'1810-K

Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.

INMD Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

INMD quarterly financial ratios
MetricQ4'2520-FQ4'2420-FQ4'2310-KQ4'2210-KQ4'2110-KQ4'2010-KQ4'1910-KQ4'1810-K
Current Ratio9.88-0.4x10.23-3.0x13.18+5.5x7.67-1.4x9.07+0.8x8.27+1.7x6.56+3.9x2.64
Debt-to-Equity0.120.0x0.120.0x0.10-0.1x0.160.0x0.150.0x0.16-0.1x0.22-0.6x0.79

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Inmode Ltd. INMD FY2025 $370.5M $93.8M 25.3% $851.1M 74/100
Iradimed Corp IRMD FY2025 $83.8M $22.5M 26.8% $1.1B 86/100
Integra Lifesciences Hldgs Cp IART FY2025 $1.6B -$516.8M -31.6% $1.3B 37/100
Tandem Diabetes TNDM FY2025 $1.0B -$204.7M -20.2% $1.4B 40/100
SS Innovations SSII FY2025 $42.5M -$12.1M -28.5% $655.3M 38/100
Beta Bionics, Inc. BBNX FY2025 $100.3M -$73.2M -73.0% $869.7M 66/100

Frequently Asked Questions

What is Inmode Ltd.'s annual revenue?

Inmode Ltd. (INMD) reported $370.5M in total revenue for fiscal year 2025. This represents a -6.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Inmode Ltd.'s revenue growing?

Inmode Ltd. (INMD) revenue declined by 6.2% year-over-year, from $394.8M to $370.5M in fiscal year 2025.

Is Inmode Ltd. profitable?

Yes, Inmode Ltd. (INMD) reported a net income of $93.8M in fiscal year 2025, with a net profit margin of 25.3%.

Inmode Ltd. (INMD) reported diluted earnings per share of $1.43 for fiscal year 2025. This represents a -36.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Inmode Ltd. (INMD) had EBITDA of $86.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Inmode Ltd. (INMD) had a gross margin of 78.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Inmode Ltd. (INMD) had an operating margin of 23.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Inmode Ltd. (INMD) had a net profit margin of 25.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Inmode Ltd. (INMD) has a return on equity of 13.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Inmode Ltd. (INMD) generated $84.3M in free cash flow during fiscal year 2025. This represents a -36.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Inmode Ltd. (INMD) generated $85.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Inmode Ltd. (INMD) had $766.4M in total assets as of fiscal year 2025, including both current and long-term assets.

Inmode Ltd. (INMD) invested $972K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Inmode Ltd. (INMD) invested $13.3M in research and development during fiscal year 2025.

Yes, Inmode Ltd. (INMD) spent $127.4M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Inmode Ltd. (INMD) had 63M shares outstanding as of fiscal year 2025.

Inmode Ltd. (INMD) had a current ratio of 9.88 as of fiscal year 2025, which is generally considered healthy.

Inmode Ltd. (INMD) had a debt-to-equity ratio of 0.12 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Inmode Ltd. (INMD) had a return on assets of 12.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Inmode Ltd. (INMD) trades at 9.1x earnings, its market capitalization divided by net income of $93.8M net income, FY2025. The market capitalization is $851.1M as of Sep 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Inmode Ltd. (INMD) trades at 2.3x sales, its market capitalization divided by revenue of $370.5M revenue, FY2025. The market capitalization is $851.1M as of Sep 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Inmode Ltd. (INMD) has an Altman Z-Score of 9.74, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Inmode Ltd. (INMD) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Inmode Ltd. (INMD) has an earnings quality ratio of 0.91x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Inmode Ltd. (INMD) scores 74 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top